Skip to main content

Table 3 Quantification of the immunostaining by the integrated pixel density – ratio ipsi/contralateral (%)

From: Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair

Antibody Anti-VGLUT1 Anti-S100 Anti-neurofilament Anti-ChAT
N (norm) 66.19 ± 7.752 150.6 ± 15.67 35.18 ± 2.189 47.66 ± 5.526
N + F 57.04 ± 9.484 100.5 ± 9.04 29.51 ± 3.091 50.26 ± 7.681
N + F + D 54.36 ± 6.536 80.04 ± 6.90 38.15 ± 2.819 48.95 ± 5.090
N + F + W 73.84 ± 6.312 96.24 ± 4.91 35.18 ± 3.739 53.51 ± 7.145
N + F + T 81.91 ± 10.41 131.5 ± 16.37 39.56 ± 1.682 56.79 ± 6.056
N + F + D + T 107.3 ± 15.88 99.7 ± 12.42 39.30 ± 4.336 61.13 ± 5.792
  1. N neurorrhaphy, F heterologous fibrin sealant, D doxycycline, W wild-type hESCs, T transgenic hESCs